This Hot Growth Stock Is Still a Buy After Enormous Gains
Although the stock market has been struggling for most of the year, some companies have performed very well. Biotech giant Vertex Pharmaceuticals (NASDAQ: VRTX) is an excellent example. The drugmaker's shares are up by 30% year to date, while the S&P 500 is down by nearly 21%. Although Vertex Pharmaceuticals is firing on all cylinders, the future could be even brighter. Let's consider why this biotech company is still worth investing in.
Source Fool.com